Biosensor identifies pancreatic cancer in early stages (IMAGE)
Caption
The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal
Credit
Gabriella Soares
Usage Restrictions
No
License
Original content